BioCentury
ARTICLE | Company News

Icagen, NPS Allelix, University of California deal

August 7, 2000 7:00 AM UTC

ICAgen received from NPS Allelix, a subsidiary of NPS Pharmaceuticals Inc. (NPSP; TSE:NX, Salt Lake City, Utah), an exclusive license to sodium channels expressed in peripheral nerve cells that regulate cellular excitability in pain pathways. ...